drugset / Trial / NCT00877357

Safety, Long Term Immunogenicity and Lot Consistency Study of Liquid Pentavalent Combination Vaccine

NCT00877357 ↗

Phase 4 Unknown 3000 enrolled Shantha Biotechnics Limited
RandomizedParallel-groupOpen-labelPrevention

Summary

A randomized phase IV study of the liquid pentavalent combination vaccine to evaluate the safety, immunogenicity (short term and long term) and clinical consistency of three production lots of the vaccine.

Timeline

Start
2009-01
Primary completion
2012-12
Completion
2013-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Shan 5 Vaccine — —